Chikungunya isn't prevalent in the U.S., but travelers are being told to be cautious about getting the vaccine for the disease.

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a live, weakened form of the virus to trigger immunity.

Discover Black Nose Disease, an alarming new symptom of Chikungunya. Learn about its causes, health risks, and the importance of early diagnosis and treatment in managing this emerging health threat.

The EMA now advises against using the drug for people aged over 65 after 17 serious adverse effects were recorded in this age ...

As this mosquito-borne viral disease continues to wreak havoc, it is essential to understand its causes, symptoms, and preventive measures. Chikungunya is a viral infection transmitted by Aedes ...

The French biotech’s VLA1553 vaccine has been cleared under the Ixchiq brand for use in people aged 18 and over who are at increased risk of exposure to chikungunya, which causes fever and ...

Valneva is a specialty vaccine developer based in France. Chikungunya is a tropical illness spread by mosquito bites. It causes fever and painful joints. About 100 to 200 U.S. travelers get the ...

Hospitals in Pakistan’s largest city, Karachi, are brimming with chikungunya virus patients. Major government hospitals throughout the city are reporting 500 to 750 suspected cases of the ...